nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—GGPS1—connective tissue—systemic scleroderma	0.0137	0.133	CbGeAlD
Zoledronate—GGPS1—tendon—systemic scleroderma	0.00941	0.0915	CbGeAlD
Zoledronate—GGPS1—lung—systemic scleroderma	0.00825	0.0803	CbGeAlD
Zoledronate—CA12—connective tissue—systemic scleroderma	0.00638	0.062	CbGeAlD
Zoledronate—FDPS—connective tissue—systemic scleroderma	0.00631	0.0614	CbGeAlD
Zoledronate—FDPS—smooth muscle tissue—systemic scleroderma	0.00577	0.0561	CbGeAlD
Zoledronate—FDPS—skin of body—systemic scleroderma	0.0057	0.0554	CbGeAlD
Zoledronate—CA14—tendon—systemic scleroderma	0.00562	0.0547	CbGeAlD
Zoledronate—CA12—digestive system—systemic scleroderma	0.00461	0.0448	CbGeAlD
Zoledronate—FDPS—digestive system—systemic scleroderma	0.00456	0.0443	CbGeAlD
Zoledronate—FDPS—tendon—systemic scleroderma	0.00434	0.0422	CbGeAlD
Zoledronate—CA12—lung—systemic scleroderma	0.00385	0.0374	CbGeAlD
Zoledronate—FDPS—lung—systemic scleroderma	0.00381	0.037	CbGeAlD
Zoledronate—CA2—connective tissue—systemic scleroderma	0.00328	0.0319	CbGeAlD
Zoledronate—CA2—smooth muscle tissue—systemic scleroderma	0.003	0.0291	CbGeAlD
Zoledronate—CA2—skin of body—systemic scleroderma	0.00296	0.0288	CbGeAlD
Zoledronate—ABCC1—tendon—systemic scleroderma	0.00252	0.0245	CbGeAlD
Zoledronate—CA2—digestive system—systemic scleroderma	0.00237	0.023	CbGeAlD
Zoledronate—CA2—tendon—systemic scleroderma	0.00225	0.0219	CbGeAlD
Zoledronate—ABCC1—lung—systemic scleroderma	0.00221	0.0215	CbGeAlD
Zoledronate—CA2—lung—systemic scleroderma	0.00198	0.0192	CbGeAlD
Zoledronate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000593	0.000661	CcSEcCtD
Zoledronate—Weight decreased—Prednisone—systemic scleroderma	0.000591	0.000659	CcSEcCtD
Zoledronate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000658	CcSEcCtD
Zoledronate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000586	0.000653	CcSEcCtD
Zoledronate—Hypotension—Lisinopril—systemic scleroderma	0.000584	0.000651	CcSEcCtD
Zoledronate—Dizziness—Captopril—systemic scleroderma	0.000584	0.000651	CcSEcCtD
Zoledronate—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000582	0.000648	CcSEcCtD
Zoledronate—Depression—Prednisone—systemic scleroderma	0.000581	0.000647	CcSEcCtD
Zoledronate—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00058	0.000646	CcSEcCtD
Zoledronate—Urticaria—Leflunomide—systemic scleroderma	0.000578	0.000644	CcSEcCtD
Zoledronate—Body temperature increased—Leflunomide—systemic scleroderma	0.000575	0.000641	CcSEcCtD
Zoledronate—Abdominal pain—Leflunomide—systemic scleroderma	0.000575	0.000641	CcSEcCtD
Zoledronate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000572	0.000638	CcSEcCtD
Zoledronate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000572	0.000637	CcSEcCtD
Zoledronate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000572	0.000637	CcSEcCtD
Zoledronate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000572	0.000637	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00057	0.000635	CcSEcCtD
Zoledronate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00057	0.000635	CcSEcCtD
Zoledronate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000568	0.000633	CcSEcCtD
Zoledronate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000568	0.000633	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000568	0.000633	CcSEcCtD
Zoledronate—Insomnia—Lisinopril—systemic scleroderma	0.000566	0.00063	CcSEcCtD
Zoledronate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000565	0.000629	CcSEcCtD
Zoledronate—Paraesthesia—Lisinopril—systemic scleroderma	0.000562	0.000626	CcSEcCtD
Zoledronate—Vomiting—Captopril—systemic scleroderma	0.000562	0.000626	CcSEcCtD
Zoledronate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000559	0.000623	CcSEcCtD
Zoledronate—Dyspnoea—Lisinopril—systemic scleroderma	0.000558	0.000621	CcSEcCtD
Zoledronate—Rash—Captopril—systemic scleroderma	0.000557	0.000621	CcSEcCtD
Zoledronate—Dermatitis—Captopril—systemic scleroderma	0.000556	0.00062	CcSEcCtD
Zoledronate—Somnolence—Lisinopril—systemic scleroderma	0.000556	0.00062	CcSEcCtD
Zoledronate—Headache—Captopril—systemic scleroderma	0.000553	0.000617	CcSEcCtD
Zoledronate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000553	0.000616	CcSEcCtD
Zoledronate—Dyspepsia—Lisinopril—systemic scleroderma	0.000551	0.000614	CcSEcCtD
Zoledronate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000549	0.000612	CcSEcCtD
Zoledronate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000549	0.000612	CcSEcCtD
Zoledronate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000548	0.000611	CcSEcCtD
Zoledronate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000548	0.000611	CcSEcCtD
Zoledronate—Asthma—Methotrexate—systemic scleroderma	0.000546	0.000608	CcSEcCtD
Zoledronate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000544	0.000607	CcSEcCtD
Zoledronate—Decreased appetite—Lisinopril—systemic scleroderma	0.000544	0.000606	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00054	0.000602	CcSEcCtD
Zoledronate—Fatigue—Lisinopril—systemic scleroderma	0.000539	0.000601	CcSEcCtD
Zoledronate—Shock—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000601	CcSEcCtD
Zoledronate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000537	0.000599	CcSEcCtD
Zoledronate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000537	0.000598	CcSEcCtD
Zoledronate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000536	0.000598	CcSEcCtD
Zoledronate—Pain—Lisinopril—systemic scleroderma	0.000535	0.000596	CcSEcCtD
Zoledronate—Constipation—Lisinopril—systemic scleroderma	0.000535	0.000596	CcSEcCtD
Zoledronate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000535	0.000596	CcSEcCtD
Zoledronate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000532	0.000593	CcSEcCtD
Zoledronate—Bradycardia—Prednisone—systemic scleroderma	0.000532	0.000593	CcSEcCtD
Zoledronate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00053	0.00059	CcSEcCtD
Zoledronate—Diarrhoea—Azathioprine—systemic scleroderma	0.000527	0.000588	CcSEcCtD
Zoledronate—Nausea—Captopril—systemic scleroderma	0.000525	0.000585	CcSEcCtD
Zoledronate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000523	0.000583	CcSEcCtD
Zoledronate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000582	CcSEcCtD
Zoledronate—Asthenia—Leflunomide—systemic scleroderma	0.000522	0.000582	CcSEcCtD
Zoledronate—Pancytopenia—Methotrexate—systemic scleroderma	0.000518	0.000578	CcSEcCtD
Zoledronate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000515	0.000574	CcSEcCtD
Zoledronate—Pruritus—Leflunomide—systemic scleroderma	0.000515	0.000574	CcSEcCtD
Zoledronate—Connective tissue disorder—Prednisone—systemic scleroderma	0.000514	0.000573	CcSEcCtD
Zoledronate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000512	0.000571	CcSEcCtD
Zoledronate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000511	0.00057	CcSEcCtD
Zoledronate—Neutropenia—Methotrexate—systemic scleroderma	0.00051	0.000569	CcSEcCtD
Zoledronate—Dizziness—Azathioprine—systemic scleroderma	0.00051	0.000568	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000507	0.000565	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000499	0.000556	CcSEcCtD
Zoledronate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000498	0.000555	CcSEcCtD
Zoledronate—Diarrhoea—Leflunomide—systemic scleroderma	0.000498	0.000555	CcSEcCtD
Zoledronate—Urticaria—Lisinopril—systemic scleroderma	0.000497	0.000554	CcSEcCtD
Zoledronate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000496	0.000552	CcSEcCtD
Zoledronate—Abdominal pain—Lisinopril—systemic scleroderma	0.000494	0.000551	CcSEcCtD
Zoledronate—Body temperature increased—Lisinopril—systemic scleroderma	0.000494	0.000551	CcSEcCtD
Zoledronate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000548	CcSEcCtD
Zoledronate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000491	0.000548	CcSEcCtD
Zoledronate—Vomiting—Azathioprine—systemic scleroderma	0.00049	0.000546	CcSEcCtD
Zoledronate—Eye disorder—Prednisone—systemic scleroderma	0.000489	0.000545	CcSEcCtD
Zoledronate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000489	0.000545	CcSEcCtD
Zoledronate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000487	0.000543	CcSEcCtD
Zoledronate—Infestation NOS—Methotrexate—systemic scleroderma	0.000487	0.000543	CcSEcCtD
Zoledronate—Infestation—Methotrexate—systemic scleroderma	0.000487	0.000543	CcSEcCtD
Zoledronate—Rash—Azathioprine—systemic scleroderma	0.000486	0.000542	CcSEcCtD
Zoledronate—Dermatitis—Azathioprine—systemic scleroderma	0.000486	0.000541	CcSEcCtD
Zoledronate—Depression—Methotrexate—systemic scleroderma	0.000485	0.000541	CcSEcCtD
Zoledronate—Flushing—Prednisone—systemic scleroderma	0.000485	0.000541	CcSEcCtD
Zoledronate—Headache—Azathioprine—systemic scleroderma	0.000483	0.000538	CcSEcCtD
Zoledronate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000482	0.000538	CcSEcCtD
Zoledronate—Dizziness—Leflunomide—systemic scleroderma	0.000481	0.000536	CcSEcCtD
Zoledronate—Renal failure—Methotrexate—systemic scleroderma	0.000478	0.000533	CcSEcCtD
Zoledronate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000476	0.000531	CcSEcCtD
Zoledronate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000475	0.00053	CcSEcCtD
Zoledronate—Stomatitis—Methotrexate—systemic scleroderma	0.000474	0.000529	CcSEcCtD
Zoledronate—Angiopathy—Prednisone—systemic scleroderma	0.000474	0.000529	CcSEcCtD
Zoledronate—Conjunctivitis—Methotrexate—systemic scleroderma	0.000473	0.000527	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000473	0.000527	CcSEcCtD
Zoledronate—Immune system disorder—Prednisone—systemic scleroderma	0.000472	0.000526	CcSEcCtD
Zoledronate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000522	CcSEcCtD
Zoledronate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000522	CcSEcCtD
Zoledronate—Arrhythmia—Prednisone—systemic scleroderma	0.000467	0.000521	CcSEcCtD
Zoledronate—Haematuria—Methotrexate—systemic scleroderma	0.000464	0.000517	CcSEcCtD
Zoledronate—Vomiting—Leflunomide—systemic scleroderma	0.000463	0.000516	CcSEcCtD
Zoledronate—Alopecia—Prednisone—systemic scleroderma	0.000462	0.000515	CcSEcCtD
Zoledronate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000461	0.000514	CcSEcCtD
Zoledronate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000459	0.000512	CcSEcCtD
Zoledronate—Rash—Leflunomide—systemic scleroderma	0.000459	0.000512	CcSEcCtD
Zoledronate—Dermatitis—Leflunomide—systemic scleroderma	0.000458	0.000511	CcSEcCtD
Zoledronate—Mental disorder—Prednisone—systemic scleroderma	0.000458	0.000511	CcSEcCtD
Zoledronate—Nausea—Azathioprine—systemic scleroderma	0.000458	0.00051	CcSEcCtD
Zoledronate—Headache—Leflunomide—systemic scleroderma	0.000456	0.000508	CcSEcCtD
Zoledronate—Malnutrition—Prednisone—systemic scleroderma	0.000455	0.000507	CcSEcCtD
Zoledronate—Erythema—Prednisone—systemic scleroderma	0.000455	0.000507	CcSEcCtD
Zoledronate—Agranulocytosis—Methotrexate—systemic scleroderma	0.000454	0.000506	CcSEcCtD
Zoledronate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000503	CcSEcCtD
Zoledronate—Asthenia—Lisinopril—systemic scleroderma	0.000449	0.0005	CcSEcCtD
Zoledronate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000448	0.000499	CcSEcCtD
Zoledronate—Pruritus—Lisinopril—systemic scleroderma	0.000442	0.000493	CcSEcCtD
Zoledronate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000441	0.000492	CcSEcCtD
Zoledronate—Rash—Mycophenolic acid—systemic scleroderma	0.000438	0.000488	CcSEcCtD
Zoledronate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000437	0.000488	CcSEcCtD
Zoledronate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000485	CcSEcCtD
Zoledronate—Headache—Mycophenolic acid—systemic scleroderma	0.000435	0.000485	CcSEcCtD
Zoledronate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000483	CcSEcCtD
Zoledronate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000483	CcSEcCtD
Zoledronate—Nausea—Leflunomide—systemic scleroderma	0.000432	0.000482	CcSEcCtD
Zoledronate—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000431	0.000481	CcSEcCtD
Zoledronate—Vision blurred—Prednisone—systemic scleroderma	0.000429	0.000478	CcSEcCtD
Zoledronate—Urethral disorder—Methotrexate—systemic scleroderma	0.000428	0.000477	CcSEcCtD
Zoledronate—Diarrhoea—Lisinopril—systemic scleroderma	0.000428	0.000477	CcSEcCtD
Zoledronate—Ill-defined disorder—Prednisone—systemic scleroderma	0.000422	0.000471	CcSEcCtD
Zoledronate—Anaemia—Prednisone—systemic scleroderma	0.000421	0.000469	CcSEcCtD
Zoledronate—Agitation—Prednisone—systemic scleroderma	0.000418	0.000466	CcSEcCtD
Zoledronate—Angioedema—Prednisone—systemic scleroderma	0.000416	0.000464	CcSEcCtD
Zoledronate—Dizziness—Lisinopril—systemic scleroderma	0.000414	0.000461	CcSEcCtD
Zoledronate—Nausea—Mycophenolic acid—systemic scleroderma	0.000412	0.00046	CcSEcCtD
Zoledronate—Malaise—Prednisone—systemic scleroderma	0.00041	0.000457	CcSEcCtD
Zoledronate—Vertigo—Prednisone—systemic scleroderma	0.000409	0.000456	CcSEcCtD
Zoledronate—Eye disorder—Methotrexate—systemic scleroderma	0.000408	0.000455	CcSEcCtD
Zoledronate—Syncope—Prednisone—systemic scleroderma	0.000408	0.000455	CcSEcCtD
Zoledronate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000406	0.000452	CcSEcCtD
Zoledronate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000404	0.00045	CcSEcCtD
Zoledronate—Loss of consciousness—Prednisone—systemic scleroderma	0.0004	0.000446	CcSEcCtD
Zoledronate—Vomiting—Lisinopril—systemic scleroderma	0.000398	0.000443	CcSEcCtD
Zoledronate—Angiopathy—Methotrexate—systemic scleroderma	0.000396	0.000442	CcSEcCtD
Zoledronate—Immune system disorder—Methotrexate—systemic scleroderma	0.000395	0.00044	CcSEcCtD
Zoledronate—Rash—Lisinopril—systemic scleroderma	0.000394	0.00044	CcSEcCtD
Zoledronate—Convulsion—Prednisone—systemic scleroderma	0.000394	0.00044	CcSEcCtD
Zoledronate—Dermatitis—Lisinopril—systemic scleroderma	0.000394	0.000439	CcSEcCtD
Zoledronate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000394	0.000439	CcSEcCtD
Zoledronate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000393	0.000438	CcSEcCtD
Zoledronate—Hypertension—Prednisone—systemic scleroderma	0.000393	0.000438	CcSEcCtD
Zoledronate—Chills—Methotrexate—systemic scleroderma	0.000392	0.000437	CcSEcCtD
Zoledronate—Headache—Lisinopril—systemic scleroderma	0.000392	0.000437	CcSEcCtD
Zoledronate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000432	CcSEcCtD
Zoledronate—Arthralgia—Prednisone—systemic scleroderma	0.000387	0.000432	CcSEcCtD
Zoledronate—Myalgia—Prednisone—systemic scleroderma	0.000387	0.000432	CcSEcCtD
Zoledronate—Anxiety—Prednisone—systemic scleroderma	0.000386	0.00043	CcSEcCtD
Zoledronate—Alopecia—Methotrexate—systemic scleroderma	0.000386	0.00043	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000385	0.000429	CcSEcCtD
Zoledronate—Discomfort—Prednisone—systemic scleroderma	0.000383	0.000427	CcSEcCtD
Zoledronate—Mental disorder—Methotrexate—systemic scleroderma	0.000383	0.000427	CcSEcCtD
Zoledronate—Malnutrition—Methotrexate—systemic scleroderma	0.00038	0.000424	CcSEcCtD
Zoledronate—Erythema—Methotrexate—systemic scleroderma	0.00038	0.000424	CcSEcCtD
Zoledronate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000375	0.000418	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—systemic scleroderma	0.000372	0.000415	CcSEcCtD
Zoledronate—Nausea—Lisinopril—systemic scleroderma	0.000371	0.000414	CcSEcCtD
Zoledronate—Oedema—Prednisone—systemic scleroderma	0.000371	0.000414	CcSEcCtD
Zoledronate—Anaphylactic shock—Prednisone—systemic scleroderma	0.000371	0.000414	CcSEcCtD
Zoledronate—Infection—Prednisone—systemic scleroderma	0.000369	0.000411	CcSEcCtD
Zoledronate—Back pain—Methotrexate—systemic scleroderma	0.000368	0.00041	CcSEcCtD
Zoledronate—Shock—Prednisone—systemic scleroderma	0.000365	0.000407	CcSEcCtD
Zoledronate—Nervous system disorder—Prednisone—systemic scleroderma	0.000364	0.000406	CcSEcCtD
Zoledronate—Tachycardia—Prednisone—systemic scleroderma	0.000363	0.000404	CcSEcCtD
Zoledronate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000362	0.000404	CcSEcCtD
Zoledronate—Skin disorder—Prednisone—systemic scleroderma	0.000361	0.000402	CcSEcCtD
Zoledronate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000359	0.0004	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—systemic scleroderma	0.000358	0.0004	CcSEcCtD
Zoledronate—Anorexia—Prednisone—systemic scleroderma	0.000354	0.000395	CcSEcCtD
Zoledronate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000353	0.000393	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—systemic scleroderma	0.000352	0.000392	CcSEcCtD
Zoledronate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000388	CcSEcCtD
Zoledronate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000346	0.000385	CcSEcCtD
Zoledronate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000385	CcSEcCtD
Zoledronate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000383	CcSEcCtD
Zoledronate—Malaise—Methotrexate—systemic scleroderma	0.000343	0.000382	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—systemic scleroderma	0.000342	0.000381	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—systemic scleroderma	0.00034	0.000379	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000338	0.000377	CcSEcCtD
Zoledronate—Insomnia—Prednisone—systemic scleroderma	0.000336	0.000374	CcSEcCtD
Zoledronate—Paraesthesia—Prednisone—systemic scleroderma	0.000334	0.000372	CcSEcCtD
Zoledronate—Cough—Methotrexate—systemic scleroderma	0.000332	0.00037	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—systemic scleroderma	0.00033	0.000367	CcSEcCtD
Zoledronate—Dyspepsia—Prednisone—systemic scleroderma	0.000327	0.000364	CcSEcCtD
Zoledronate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000363	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—systemic scleroderma	0.000324	0.000361	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—systemic scleroderma	0.000324	0.000361	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—systemic scleroderma	0.000324	0.000361	CcSEcCtD
Zoledronate—Decreased appetite—Prednisone—systemic scleroderma	0.000323	0.00036	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000322	0.000358	CcSEcCtD
Zoledronate—Fatigue—Prednisone—systemic scleroderma	0.00032	0.000357	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—systemic scleroderma	0.00032	0.000357	CcSEcCtD
Zoledronate—Constipation—Prednisone—systemic scleroderma	0.000318	0.000354	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—systemic scleroderma	0.000313	0.000349	CcSEcCtD
Zoledronate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00031	0.000346	CcSEcCtD
Zoledronate—Infection—Methotrexate—systemic scleroderma	0.000308	0.000344	CcSEcCtD
Zoledronate—Feeling abnormal—Prednisone—systemic scleroderma	0.000306	0.000341	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000304	0.000339	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000304	0.000339	CcSEcCtD
Zoledronate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000304	0.000339	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—systemic scleroderma	0.000302	0.000336	CcSEcCtD
Zoledronate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.0003	0.000334	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—systemic scleroderma	0.000296	0.00033	CcSEcCtD
Zoledronate—Urticaria—Prednisone—systemic scleroderma	0.000295	0.000329	CcSEcCtD
Zoledronate—Abdominal pain—Prednisone—systemic scleroderma	0.000294	0.000327	CcSEcCtD
Zoledronate—Body temperature increased—Prednisone—systemic scleroderma	0.000294	0.000327	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—systemic scleroderma	0.00029	0.000323	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000283	0.000315	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—systemic scleroderma	0.000281	0.000313	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—systemic scleroderma	0.000279	0.000311	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—systemic scleroderma	0.000277	0.000308	CcSEcCtD
Zoledronate—Somnolence—Methotrexate—systemic scleroderma	0.000276	0.000308	CcSEcCtD
Zoledronate—Hypersensitivity—Prednisone—systemic scleroderma	0.000274	0.000305	CcSEcCtD
Zoledronate—Dyspepsia—Methotrexate—systemic scleroderma	0.000273	0.000305	CcSEcCtD
Zoledronate—Decreased appetite—Methotrexate—systemic scleroderma	0.00027	0.000301	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000268	0.000299	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—systemic scleroderma	0.000268	0.000298	CcSEcCtD
Zoledronate—Asthenia—Prednisone—systemic scleroderma	0.000266	0.000297	CcSEcCtD
Zoledronate—Pain—Methotrexate—systemic scleroderma	0.000265	0.000296	CcSEcCtD
Zoledronate—Pruritus—Prednisone—systemic scleroderma	0.000263	0.000293	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000256	0.000285	CcSEcCtD
Zoledronate—Diarrhoea—Prednisone—systemic scleroderma	0.000254	0.000283	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000254	0.000283	CcSEcCtD
Zoledronate—Urticaria—Methotrexate—systemic scleroderma	0.000247	0.000275	CcSEcCtD
Zoledronate—Dizziness—Prednisone—systemic scleroderma	0.000246	0.000274	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—systemic scleroderma	0.000245	0.000274	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—systemic scleroderma	0.000245	0.000274	CcSEcCtD
Zoledronate—Vomiting—Prednisone—systemic scleroderma	0.000236	0.000263	CcSEcCtD
Zoledronate—Rash—Prednisone—systemic scleroderma	0.000234	0.000261	CcSEcCtD
Zoledronate—Dermatitis—Prednisone—systemic scleroderma	0.000234	0.000261	CcSEcCtD
Zoledronate—Headache—Prednisone—systemic scleroderma	0.000233	0.000259	CcSEcCtD
Zoledronate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000229	0.000255	CcSEcCtD
Zoledronate—Asthenia—Methotrexate—systemic scleroderma	0.000223	0.000248	CcSEcCtD
Zoledronate—Nausea—Prednisone—systemic scleroderma	0.000221	0.000246	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—systemic scleroderma	0.00022	0.000245	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—systemic scleroderma	0.000212	0.000237	CcSEcCtD
Zoledronate—Dizziness—Methotrexate—systemic scleroderma	0.000205	0.000229	CcSEcCtD
Zoledronate—Vomiting—Methotrexate—systemic scleroderma	0.000197	0.00022	CcSEcCtD
Zoledronate—Rash—Methotrexate—systemic scleroderma	0.000196	0.000218	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—systemic scleroderma	0.000196	0.000218	CcSEcCtD
Zoledronate—Headache—Methotrexate—systemic scleroderma	0.000194	0.000217	CcSEcCtD
Zoledronate—Nausea—Methotrexate—systemic scleroderma	0.000184	0.000206	CcSEcCtD
